US BANCORP \DE\ - PULMONX CORP ownership

PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 117 filers reported holding PULMONX CORP in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of PULMONX CORP
ValueSharesWeighting
Q3 2023$1,818
-91.3%
176
-88.9%
0.00%
Q2 2023$20,792
-19.7%
1,586
-31.5%
0.00%
Q1 2023$25,893
+337.5%
2,316
+229.9%
0.00%
Q4 2022$5,918
-15.5%
702
+75.5%
0.00%
Q3 2022$7,0000.0%400
-14.2%
0.00%
Q2 2022$7,000
-30.0%
466
+23.6%
0.00%
Q1 2022$10,000
-80.4%
377
-76.3%
0.00%
Q4 2021$51,000
+37.8%
1,590
+54.4%
0.00%
Q3 2021$37,000
+68.2%
1,030
+107.7%
0.00%
Q2 2021$22,0004960.00%
Other shareholders
PULMONX CORP shareholders Q3 2023
NameSharesValueWeighting ↓
ABG-WTT Global Life Science Capital Partners GP Ltd 60,204$886,0003.13%
PURA VIDA INVESTMENTS, LLC 1,327,065$19,534,0001.13%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,465,901$51,018,0001.05%
NEXT CENTURY GROWTH INVESTORS LLC 453,098$6,669,0000.87%
Novo Holdings A/S 510,555$7,515,0000.37%
Rock Springs Capital Management LP 702,400$10,339,0000.30%
RTW INVESTMENTS, LP 691,255$10,175,0000.26%
TimesSquare Capital Management, LLC 1,214,204$17,873,0000.25%
FORMULA GROWTH LTD 54,951$809,0000.22%
Champlain Investment Partners, LLC 2,129,760$31,350,0000.20%
View complete list of PULMONX CORP shareholders